On September 10, 2024, Neurode announced that it has raised $3.5 million in pre-Seed funding and is launching its private beta which users can join now at neurodelabs.com.

The Sydney, Australia-based company is pioneering a wearable headband to track and treat ADHD symptoms using light electrical stimulation in the prefrontal cortex. The headband is currently available through a private beta and Neurode plans to seek FDA approval for the device in the future. The pre-Seed funding round was led by Khosla Ventures, with participation from PsyMed Ventures. Neurode, which filed patents for its device in 2021, has used the funding to support clinical trials.

Wilson Sonsini Goodrich & Rosati represented Neurode in the transaction. The Wilson Sonsini team includes Lang Liu and Will Andrews.

For more information, please see news coverage by TechCrunch.